tenk.fyi

EXELIXIS, INC.

EXELNasdaq· Biological Products, (No Diagnostic Substances)

Price History

Revenue

$2.3B

7.0% YoY

Net Income

$782.6M

50.1% YoY

EPS

$2.78

58.0% YoY

Cash

$482.5M

122.0% YoY

FY 2026 · As of 2026-01-02